Answers are grounded in this paper and cite their sources.
Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of precision medicine in gastrointestinal disorders.
No takes yet. Share an insight, caveat, or question.
Benech et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: